Literature DB >> 11772012

Effects of nucleotide analogues on Euplotes aediculatus telomerase processivity: evidence for product-assisted translocation.

Michael B Jarstfer1, Thomas R Cech.   

Abstract

Telomerase is a unique ribonucleoprotein that reverse transcribes a defined region of its RNA subunit onto the ends of eukaryotic chromosomes. The product of telomerase, telomeric DNA, is typically a G-rich repeated sequence, (TTTTGGGG)(n) in the ciliate Euplotes aediculatus and (TTAGGG)(n) in humans. Telomerase can extend oligonucleotide primers in vitro in a processive fashion. We used dNTP analogues to study the structure-activity relationship between substrate nucleotides and processivity of telomerase from E. aediculatus. Several analogues, including 2'-deoxyuridine triphosphate (dUTP), 2'-deoxyinosine triphosphate (dITP), and 7-deaza-2'-deoxyguanosine triphosphate (7-deaza-dGTP), were good substrates for telomerase with K(m) and V(max) values near those of the natural substrates, dTTP and dGTP. However, telomerase processivity was affected with these substrates, decreasing in the order dUTP > 7-deaza-dGTP > dITP. Telomerase did not completely reverse transcribe the template when dITP was the substrate, and it efficiently extended a primer by the addition of two repeats when 7-deaza-dGTP and dUTP were utilized. When the same nucleotide analogues were incorporated into the primers, no effects were observed except in the case of a 3'-terminal deoxyinosine. The data support a model that includes the formation of an intramolecular secondary structure within the product DNA to facilitate translocation. The most likely structure is a G-G hairpin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11772012     DOI: 10.1021/bi011649z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  hnRNP A1 associates with telomere ends and stimulates telomerase activity.

Authors:  Qing-Shuo Zhang; Lisa Manche; Rui-Ming Xu; Adrian R Krainer
Journal:  RNA       Date:  2006-04-07       Impact factor: 4.942

2.  ESI-MS Investigation of an Equilibrium between a Bimolecular Quadruplex DNA and a Duplex DNA/RNA Hybrid.

Authors:  Monica L Birrento; Tracy M Bryan; Siritron Samosorn; Jennifer L Beck
Journal:  J Am Soc Mass Spectrom       Date:  2015-04-24       Impact factor: 3.109

3.  Multiple mechanisms for elongation processivity within the reconstituted tetrahymena telomerase holoenzyme.

Authors:  Bosun Min; Kathleen Collins
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

4.  Yeast telomerase is specialized for C/A-rich RNA templates.

Authors:  Klaus Förstemann; Arthur J Zaug; Thomas R Cech; Joachim Lingner
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

5.  Direct observation of nucleic acid binding dynamics by the telomerase essential N-terminal domain.

Authors:  Shankar Shastry; Olga Steinberg-Neifach; Neal Lue; Michael D Stone
Journal:  Nucleic Acids Res       Date:  2018-04-06       Impact factor: 16.971

6.  A DNA-hairpin model for repeat-addition processivity in telomere synthesis.

Authors:  Wei Yang; Young-Sam Lee
Journal:  Nat Struct Mol Biol       Date:  2015-11       Impact factor: 15.369

7.  Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis.

Authors:  Jonathan K Alder; Joy D Cogan; Andrew F Brown; Collin J Anderson; William E Lawson; Peter M Lansdorp; John A Phillips; James E Loyd; Julian J-L Chen; Mary Armanios
Journal:  PLoS Genet       Date:  2011-03-31       Impact factor: 5.917

8.  Telomere DNA G-quadruplex folding within actively extending human telomerase.

Authors:  Linnea I Jansson; Jendrik Hentschel; Joseph W Parks; Terren R Chang; Cheng Lu; Rishika Baral; Clive R Bagshaw; Michael D Stone
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-24       Impact factor: 12.779

Review 9.  G-Quadruplexes at Telomeres: Friend or Foe?

Authors:  Tracy M Bryan
Journal:  Molecules       Date:  2020-08-13       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.